Buy Rating on Akoya Biosciences: Temporary Setbacks, Growth Potential, and an Attractive Entry Point
Envista Holdings: A Cautious Hold Amidst Turnaround Efforts and Management Transition
Roth MKM Resumes Coverage of LeMaitre With Buy Rating
Navigating 4 Analyst Ratings For LeMaitre Vascular
Analysts Conflicted on These Healthcare Names: Merit Medical Systems (MMSI) and Regeneron (REGN)
Baird Adjusts Price Target on Cooper Companies to $118 From $116
LeMaitre Vascular Analyst Ratings
Buy Rating Affirmed for The Cooper Companies Inc. on Robust Q2 Earnings and Strong Growth Prospects
Cooper Companies Analyst Ratings
Lemaitre Vascular's Dominant Market Position and Growth Prospects Garner 'Buy' Rating
BioLife Solutions (BLFS) Receives a Buy From Craig-Hallum
Teleflex's Strong Market Position and Growth Opportunities Amidst Competitor Challenges: A Buy Rating Endorsement
Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Immunovant (IMVT) and Monte Rosa Therapeutics (GLUE)
Intuitive Surgical Analyst Ratings
Becton Dickinson Analyst Ratings
Baxter Intl Analyst Ratings
Anika Therapeutics Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Teleflex (TFX), Bioxcel Therapeutics (BTAI) and Prothena (PRTA)
Jefferies Keeps Their Hold Rating on Stevanato Group (STVN)
Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Intuitive Surgical (ISRG) and Silence Therapeutics (SLN)